These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 47244)

  • 1. The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):360-9. PubMed ID: 47244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):370-84. PubMed ID: 1122293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.
    Joist JH; Niewiarowski S; Nath N; Mustard JF
    J Lab Clin Med; 1976 Apr; 87(4):659-69. PubMed ID: 131845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum.
    Mui PT; James HL; Ganguly P
    Br J Haematol; 1975 Apr; 29(4):627-37. PubMed ID: 127607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation.
    Switalska HI; Niewiarowski S; Tuszynski GP; Rucinski B; Schmaier AH; Morinelli TA; Cierniewski CS
    J Lab Clin Med; 1985 Dec; 106(6):690-700. PubMed ID: 2415646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelet basic protein. Its relation to low affinity platelet factor 4 and beta-thromboglobulin.
    Varma KG; Niewiarowski S; Holt JC; Rucinski B; Paul D
    Biochim Biophys Acta; 1982 Feb; 701(1):7-11. PubMed ID: 6173075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human serum plasminogen antiactivator: its distinction from antiplasmin.
    Aoki N; Von Kaulla KN
    Am J Physiol; 1971 Apr; 220(4):1137-45. PubMed ID: 4251631
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin.
    Holt JC; Harris ME; Holt AM; Lange E; Henschen A; Niewiarowski S
    Biochemistry; 1986 Apr; 25(8):1988-96. PubMed ID: 2423119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The released proteins from avian thrombocytes.
    Wachowicz B; Krajewski T
    Thromb Haemost; 1979 Dec; 42(4):1289-95. PubMed ID: 542934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low molecular weight antiplasmin of human blood platelets.
    Ganguly P
    Clin Chim Acta; 1972 Jul; 39(2):466-8. PubMed ID: 4625471
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on an inhibitor of plasminogen activators in human platelets.
    Murray J; Crawford GP; Ogston D; Douglas AS
    Br J Haematol; 1974 Apr; 26(4):661-8. PubMed ID: 4276857
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet release protein which inhibits plasminogen activators.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1985 Jul; 38(7):825-30. PubMed ID: 3926830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement of human plasma antiplasmin activity by radial diffusion assay.
    Andes WA
    Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
    Erickson LA; Ginsberg MH; Loskutoff DJ
    J Clin Invest; 1984 Oct; 74(4):1465-72. PubMed ID: 6434594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
    Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
    J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet fibrinogen. Identity and initial observations on the mode of its degradation by plasmin.
    James HL; Bradford HR; Ganguly P
    Biochim Biophys Acta; 1975 Mar; 386(1):209-20. PubMed ID: 236019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Isolation and characterization of human platelet beta-thromboglobulin.
    Pepper DS; Moore S; Cash JD
    Thromb Diath Haemorrh; 1975 Sep; 34(1):349. PubMed ID: 52901
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.